SeaStar Medical Holding (ICU) Cash & Equivalents (2020 - 2026)

SeaStar Medical Holding (ICU) has 7 years of Cash & Equivalents data on file, last reported at $9.3 million in Q1 2026.

• Quarterly Cash & Equivalents rose 75.6% year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (up 75.6% YoY) and the FY2024 annual result came in at $1.8 million, up 933.52% from the prior year.
• Cash & Equivalents slipped to $9.3 million in Q1 2026, from $13.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $13.8 million in Q3 2025 to a low of $13000.0 in Q2 2023.
• A 5-year average of $2.9 million and a median of $952000.0 in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 97.88% — and 2024, when it surged 8969.23%.
• Tracing ICU's Cash & Equivalents over 5 years: stood at $47000.0 in 2022, then surged by 274.47% to $176000.0 in 2023, then soared by 933.52% to $1.8 million in 2024, then jumped by 656.62% to $13.8 million in 2025, then plunged by 32.43% to $9.3 million in 2026.
• The last three Cash & Equivalents figures came in at $9.3 million (Q1 2026), $13.8 million (Q3 2025), and $6.3 million (Q2 2025), per Business Quant data.